Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Glutafin gets behind Scotland’s gluten-free pilot

A campaign to help pharmacists engage with Scotland's gluten-free dispensing pilot has been launched by Glutafin.


As part of the campaign, the manufacturer created three online CPD modules for coeliac disease, accredited by the Royal Pharmaceutical Society.


It also ran free events in Edinburgh and Glasgow this week to educate pharmacists about the gluten-free scheme, said Glutafin, which has sent free support boxes to all Scottish pharmacies.


The boxes contain a coeliac disease reference book, promotional window stickers, a sample from the manufacturer's gluten-free range and a full product list.


Katie Kennedy, company dietician for the Dr Schär institute for coeliac disease, which owns Glutafin, said the campaign would give pharmacists the confidence they needed to deliver the pilot with "the greatest success".


Pharmacists should visit drschaer-institute.com to access the CPD modules. 


The support boxes can be requested from [email protected]

]]>

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD004308

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel